Nasdaq to hold Q2 2026 earnings call on July 23

0 min read     Updated on 30 Jun 2026, 01:50 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Nasdaq will announce its Q2 2026 financial results on July 23, 2026, followed by a conference call at 8:00 AM Eastern. Senior management will host the call to discuss performance. Results will be released online at 7:00 AM Eastern.

powered bylight_fuzz_icon
44309989

*this image is generated using AI for illustrative purposes only.

Nasdaq will announce its second quarter 2026 financial results on Thursday, July 23, 2026, with a conference call scheduled for 8:00 AM Eastern. The company’s CEO, CFO, and additional members of its senior management team will review the performance and answer questions from the investment community following prepared remarks. The press release and results presentation will be posted on the Nasdaq Investor Relations website at approximately 7:00 AM Eastern, prior to the call.

Investors can access the live webcast of the conference through the Nasdaq Investor Relations website. The event provides an opportunity for stakeholders to gain direct insights into the company's quarterly operational and financial metrics.

Key Event Details

Detail Information
Event Q2 2026 Financial Results Conference Call
Date Thursday, July 23, 2026
Time 8:00 AM Eastern
Webcast Available at http://ir.nasdaq.com/
Materials Release Approximately 7:00 AM Eastern

Nasdaq operates as a technology platform powering the world’s economies, providing infrastructure for modern markets and solutions for the innovation economy.

How will Nasdaq's Q2 2026 performance reflect broader trends in the global financial markets?

What strategic initiatives might Nasdaq highlight during the call to drive future growth?

How could the results impact Nasdaq's competitive position in the technology and financial infrastructure space?

like18
dislike

Universe Pharma shares surge 228% on acquisition deal

1 min read     Updated on 29 Jun 2026, 05:08 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Universe Pharmaceuticals Inc shares surged 228.4% in pre-market trading after announcing the acquisition of Best Praise International for $10.75 million. Decoy Therapeutics Inc and Viridian Therapeutics Inc also posted significant gains, while Farmmi Inc and Jupiter Neurosciences Inc led the losers.

powered bylight_fuzz_icon
44278662

*this image is generated using AI for illustrative purposes only.

Shares of Universe Pharmaceuticals Inc surged 228.4% to $9.72 in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. The acquisition drove the sharp increase in Universe Pharmaceuticals' stock price, making it one of the top gainers in the session.

Decoy Therapeutics Inc rose 227.5% to $18.07 in pre-market trading following the announcement of up to $21 million in private placement financing. INLIF Ltd gained 52% to $0.071, while Volato Group Inc increased 36.5% to $0.23. Tvardi Therapeutics Inc climbed 26.7% to $1.90 after a 36% dip on Friday.

SAGTEC GLOBAL Ltd advanced 24.7% to $1.31, recovering from a 27% decline on Friday. The company's Chairman and CEO acquired 1.5 million shares last week. Meiwu Technology Co Ltd gained 14.2% to $3.84, and Churchill Capital Corp XI rose 13.2% to $15.69 after announcing a SPAC merger with Agility Robotics.

Larimar Therapeutics Inc jumped 12.4% to $4.11, while Viridian Therapeutics Inc gained 11.5% to $19.95 following the U.S. FDA approval and launch of Lumvoa (veligrotug-vvze) for thyroid eye disease treatment.

On the downside, Farmmi Inc tumbled 60.7% to $0.48 after announcing a proposed public offering. Jupiter Neurosciences Inc fell 24.3% to $0.21 due to the resale registration of up to 16 million shares by selling stockholders. Picocela Inc – ADR declined 19.7% to $5.58, and UTStarcom Holdings Corp dipped 16.3% to $2.00.

Curis Inc fell 16.1% to $0.27, while Sadot Group Inc dropped 15.6% to $18.08 after a 247% surge on Friday. LiveWire Group Inc declined 13.8% to $1.19, and Freecast Inc fell 13.8% to $6.60. TopBuild Corp decreased 7.3% to $395.00 as Toast Inc will replace it in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, July 1. Pershing Square Inc declined 6.2% to $29.59.

Top Movers in Pre-Market Trading

Company Ticker Change Price
Universe Pharmaceuticals Inc UPC +228.4% $9.72
Decoy Therapeutics Inc DCOY +227.5% $18.07
INLIF Ltd INLF +52% $0.071
Farmmi Inc FAMI -60.7% $0.48
Jupiter Neurosciences Inc JUNS -24.3% $0.21

Will Universe Pharmaceuticals sustain its pre-market gains once the market opens, or will profit-taking occur?

How will Decoy Therapeutics utilize the $21 million in financing to advance its clinical pipeline?

What impact will Viridian Therapeutics' FDA approval for Lumvoa have on its competitive position in the thyroid eye disease market?

like17
dislike

More News on NASDAQ

Must Read Next

Earnings

Corporate Actions

Stocks